Allakos Inc (ALLK)
1.36
-0.07
(-4.90%)
USD |
NASDAQ |
May 22, 16:00
1.35
-0.01
(-0.74%)
Pre-Market: 20:00
Allakos Enterprise Value: -18.83M for May 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 22, 2024 | -18.83M |
| May 21, 2024 | -12.63M |
| May 20, 2024 | -12.63M |
| May 17, 2024 | -11.75M |
| May 16, 2024 | -10.86M |
| May 15, 2024 | -34.33M |
| May 14, 2024 | -33.88M |
| May 13, 2024 | -31.23M |
| May 10, 2024 | -33.00M |
| May 09, 2024 | -25.03M |
| May 08, 2024 | -27.69M |
| May 07, 2024 | -30.78M |
| May 06, 2024 | -35.65M |
| May 03, 2024 | -36.54M |
| May 02, 2024 | -41.85M |
| May 01, 2024 | -39.20M |
| April 30, 2024 | -46.28M |
| April 29, 2024 | -41.85M |
| April 26, 2024 | -48.94M |
| April 25, 2024 | -49.82M |
| April 24, 2024 | -48.94M |
| April 23, 2024 | -46.28M |
| April 22, 2024 | -45.39M |
| April 19, 2024 | -44.51M |
| April 18, 2024 | -45.39M |
| Date | Value |
|---|---|
| April 17, 2024 | -45.39M |
| April 16, 2024 | -46.28M |
| April 15, 2024 | -43.62M |
| April 12, 2024 | -40.97M |
| April 11, 2024 | -32.11M |
| April 10, 2024 | -36.54M |
| April 09, 2024 | -33.00M |
| April 08, 2024 | -39.20M |
| April 05, 2024 | -33.88M |
| April 04, 2024 | -30.34M |
| April 03, 2024 | -25.92M |
| April 02, 2024 | -29.46M |
| April 01, 2024 | -31.23M |
| March 28, 2024 | -59.23M |
| March 27, 2024 | -58.32M |
| March 26, 2024 | -57.44M |
| March 25, 2024 | -54.80M |
| March 22, 2024 | -52.16M |
| March 21, 2024 | -57.44M |
| March 20, 2024 | -55.68M |
| March 19, 2024 | -60.95M |
| March 18, 2024 | -62.71M |
| March 15, 2024 | -55.68M |
| March 14, 2024 | -56.12M |
| March 13, 2024 | -48.21M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-146.41M
Minimum
Mar 15 2022
7.584B
Maximum
Dec 28 2020
2.063B
Average
1.556B
Median
Jun 05 2019
Enterprise Value Benchmarks
| Tonix Pharmaceuticals Holding Corp | 20.08M |
| RAPT Therapeutics Inc | 20.02M |
| NovaBay Pharmaceuticals Inc | 5.958M |
| Palatin Technologies Inc | 22.90M |
| iBio Inc | 27.79M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -71.15M |
| Total Expenses (Quarterly) | 45.72M |
| EPS Diluted (Quarterly) | -0.81 |
| Earnings Yield | -180.9% |